Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Enoxaparin Dosing Strategies in Elderly with Renal Impairment
NCT03158792Phase 4Completed
- Sponsor
- Lebanese American University
- Start
- Oct 2015
- Primary completion
- Jul 2017
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of enoxaparin in venous thromboembolism (VTE) (2 arms), sponsored by Lebanese American University. Primary endpoint: Peak anti-Xa levels at Day 3. Started Oct 2015; status: completed.
02
Drugs
enoxaparin
03
Conditions
venous thromboembolism (VTE)
Beyond the preview
Go deeper on NCT03158792.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03158792.